Protein C Activator (PCA) AB002
A recombinant antithrombotic and cytoprotective enzyme that acts without increasing the risk of bleeding. AB002 is developed for stand-alone emergency use in high bleeding risk indications, such as acute stroke. It is currently in pre-clinical stage.
Therapeutic anticoagulant antibody AB012
A potent recombinant protein that selectively inhibits the intrinsic blood coagulation cascade upstream of coagulation factor IX (F9). AB012 is intended for use as an antithrombotic agent when the bleeding risk is moderate, including pulmonary thromboembolism and heart attack. It is currently in pre-clinical stage.
Therapeutic anticoagulant antibody AB022
A recombinant protein that selectively inhibits the intrinsic coagulation cascade upstream of coagulation factor XI (F11). AB022 is intended for use in conditions that are intrinsically accompanied with bleeding, such as major surgeries and consumptive coagulopathy. It is currently in pre-clinical stage.